Bristol Myers Squibb Non-GAAP EPS of $1.93 beats by $0.12, revenue of $11.9B beats by $400M, cuts FY22 outlook

Jul. 27, 2022 7:02 AM ETBristol-Myers Squibb Company (BMY)By: Gaurav Batavia, SA News Editor36 Comments
  • Bristol Myers Squibb press release (NYSE:BMY): Q2 Non-GAAP EPS of $1.93 beats by $0.12.
  • Revenue of $11.9B (+1.7% Y/Y) beats by $400M.
  • Delivers Robust Revenue Growth of 11% from In-Line Products and New Product Portfolio; or 16% When Adjusted for Foreign Exchange
  • FY22 Outlook: Total net sales of $46B from prior outlook of $47B vs. $46.29B consensus
  • Adj. EPS of $7.44-$7.74 from prior outlook of $7.65-$7.95 vs. $7.47 consensus
     
  • Shares -0.9% PM.

Recommended For You

Comments (36)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.